Observational Study of Rebismart®2.0 + MSdialog™ in Subjects With Remitting Multiple Sclerosis (ADHERQOL)

Clinical trial NCT02394782 · TERMINATED

Trial details

NCT number: NCT02394782
Sponsor: Merck KGaA, Darmstadt, Germany
Status: TERMINATED
Study type: OBSERVATIONAL

Multiple Sclerosis, Relapsing-remitting

Start date: 2015-02-01
Primary completion: 2015-11-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.